Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 175

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure

Open access
Mishra, Shruti, Gordon, Brian A., Su, Yi, Christensen, Jon, Friedrichsen, Karl, Jackson, Kelley, Hornbeck, Russ, Balota, David A., Cairns, Nigel J., Morris, John C., Ances, Beau M., Benzinger, Tammie L.S. · 2017 · NeuroImage

Abstract

Abstract Utilizing [18F]‐AV‐1451 tau positron emission tomography (PET) as an Alzheimer disease (AD) biomarker will require identification of brain regions that are most important in detecting elevated tau pathology in preclinical AD. Here, we utilized an unsupervised learning, data‐driven approach to identify brain regions whose tau PET is most informative in discriminating low and high levels of [18F]‐AV‐1451 binding. 84 cognitively normal participants who had undergone AV‐1451 PET imaging were used in a sparse k‐means clustering with resampling analysis to identify the regions most informative in dividing a cognitively normal population into high tau and low tau groups. The highest‐weighted FreeSurfer regions of interest (ROIs) separating these groups were the entorhinal cortex, amygdala, lateral occipital cortex, and inferior temporal cortex, and an average SUVR in these four ROIs was used as a summary metric for AV‐1451 uptake. We propose an AV‐1451 SUVR cut‐off of 1.25 to define high tau as described by imaging. This spatial distribution of tau PET is a more widespread pattern than that predicted by pathological staging schemes. Our data‐derived metric was validated first in this cognitively normal cohort by correlating with early measures of cognitive dysfunction, and with disease progression as measured by &bgr;‐amyloid PET imaging. We additionally validated this summary metric in a cohort of 13 Alzheimer disease patients, and showed that this measure correlates with cognitive dysfunction and &bgr;‐amyloid PET imaging in a diseased population. HighlightsAV‐1451 binding in four key regions identifies tau‐positive individuals with preclinical AD.The SUVR cutoff for high and low tau PET is 1.25.Increased tau PET correlates with early cognitive impairment, and relates to &bgr;‐amyloid burden in preclinical AD individuals.The spatial pattern of AV‐1451 uptake in preclinical AD is more widespread than predicted by pathological staging.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuroimage.2017.07.050

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 175

Metadata

Authors
Mishra, S., Gordon, B. A., Su, Y., Christensen, J., Friedrichsen, K., Jackson, K., Hornbeck, R., Balota, D. A., Cairns, N. J., Morris, J. C., Ances, B. M., & Benzinger, T. L. S.
Venue
NeuroImage
Publisher
Elsevier BV
Published
2017-11
Volume
161
Pages
171-178
ISSN
1053-8119 (ISSN-L)
OpenAlex
W2738088587
Cited by
175
References
26
FWCI
10.36
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.